Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Abstract Expression of the chromatin-associated protein HMGA2 correlates with progression, metastasis and therapy resistance in pancreatic ductal adenocarcinoma (PDAC). Hmga2 has also been identified as a marker of a transient subpopulation of PDAC cells that has increased metastatic ability. Here,...
Enregistré dans:
Auteurs principaux: | Shin-Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b72834b1a36a49d0bfd2fb6d72fac298 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
par: Dong-jin Wu, et autres
Publié: (2018) -
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
par: Parniyan Maneshi, et autres
Publié: (2021) -
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
par: Antonia Malinova, et autres
Publié: (2021) -
Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
par: Hongjin Wu, et autres
Publié: (2021) -
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
par: Cai,Yi, et autres
Publié: (2018)